ECONOCHLOR - chloramphenicol solution 
ECONOCHLOR - chloramphenicol ointment 
Alcon Laboratories, Inc.

----------

Econochlor®
chloramphenicol
Sterile Ophthalmic
Solution and Ointment

Bone marrow hypoplasia, including aplastic anemia and death has been reported following local application of chloramphenicol. Chloramphenicol should not be used when less potentially dangerous agents would be expected to provide effective treatment.

DESCRIPTION

ECONOCHLOR® (Chloramphenicol) is a sterile topical ophthalmic antibacterial prepared in solution and ointment forms. The active ingredient is represented by the chemical structure:

structural formula

Established name:

Chloramphenicol

Chemical name:

Acetamide, 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2- (4-nitrophenyl) ethyl]-, [R-(R*,R)]-

Each ml of solution contains: Active: Chloramphenicol 0.5% (5mg/ml). Preservative: Thimerosal 0.01%. Vehicle: Hydroxypropyl Methylcellulose: Inactive: Boric Acid, Sodium Borate (to adjust pH), Purified Water.

DM-00

Each gram of ointment contains: Active: Chloramphenicol 1.0% (10 mg/g). Inactive: Mineral Oil, Anhydrous Liquid Lanolin, White Petrolatum.

DM-00

CLINICAL PHARMACOLOGY

Chloramphenicol is a broad-spectrum antibiotic originally isolated from Streptomyces venezuelae. It is primarily bacteriostatic and acts by inhibition of protein synthesis by interfering with the transfer of activated amino acids from soluble RNA to ribosomes. Development of resistance to chloramphenicol can be regarded as minimal for staphylococci and many other species of bacteria.

INDICATIONS USAGE

Chloramphenicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. Bacteriological studies should be performed to determine the causative organisms and their sensitivity to chloramphenicol (See Box Warning). For treatment of ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol-susceptible organisms.

Chloramphenicol has a wide spectrum of antimicrobial activity and is effective against many gram negative and gram positive bacteria, including the following common eye pathogens:

Staphylococcus aureus

Streptococci, including Streptococcus pneumoniae

Escherichia coli

Haemophilus influenzae

Klebsiella/Enterobacter species

Neisseria species

Moraxella lacunata (Morax-Axenfeld bacillus)

The product does not provide adequate coverage against:

Pseudomonas aeruginosa

Serratia marcescens

CONTRAINDICATIONS

This product is contraindicated in those persons who have shown hypersensitivity to any of its components.

WARNINGS

SEE BOX WARNING.

Ophthalmic ointment may retard corneal wound healing.

PRECAUTIONS

Prolonged use of antibiotics may occasionally result in overgrowth of non-susceptible organisms, including fungi. If new infections appear during treatment, the therapy should be altered. In all serious infections, the topical use of chloramphenicol should be supplemented by appropriate systemic medication.

ADVERSE REACTIONS

Blood dyscrasias may be associated with the systemic use of chloramphenicol. One case of bone-marrow hypoplasia following the prolonged (23 month) topical use of chloramphenicol ophthalmic solution has been reported.

DOSAGE ADMINISTRATION

Solution: In severe disease, instill two drops on the eye(s) hourly until improvement, following which treatment should be diminished prior to discontinuation. In mild disease, drops may be used four times daily. Ointment: Apply a small amount to the lower conjunctival sac(s) at bedtime as a supplement to the drops.

HOW SUPPLIED

Solution in 5ml (2.5ml fill) and 15ml plastic Drop-Tainer® dispensers. Ointment in 3.5 gram ophthalmic tube. Rx only.

2.5ml NDC 0065-0642-25

15ml NDC 0065-0642-15

3.5 g NDC 0065-0641-35

STORAGE

Solution: Refrigerate until dispensed. Ointment: Store between 46° and 80°F.

June, 1984
29824
Printed in USA

Alcon
Alcon Laboratories, Inc.
Fort Worth, Texas 76134 USA

product never went to market and no packaging was designed
product never went to market and no packaging was designed
ECONOCHLOR  
chloramphenicol solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0065-0642
Route of AdministrationOPHTHALMICDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
chloramphenicol (UNII: 66974FR9Q1) (chloramphenicol - UNII:66974FR9Q1) chloramphenicol5 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
thimerosal (UNII: 2225PI3MOV)  
Hypromelloses (UNII: 3NXW29V3WO)  
boric acid (UNII: R57ZHV85D4)  
sodium borate (UNII: 91MBZ8H3QO)  
water (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0065-0642-252.5 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
2NDC:0065-0642-1515 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA06164504/26/197307/31/1990
ECONOCHLOR  
chloramphenicol ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0065-0641
Route of AdministrationOPHTHALMICDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
chloramphenicol (UNII: 66974FR9Q1) (chloramphenicol - UNII:66974FR9Q1) chloramphenicol10 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
Mineral Oil (UNII: T5L8T28FGP)  
Lanolin (UNII: 7EV65EAW6H)  
Petrolatum (UNII: 4T6H12BN9U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0065-0641-353.5 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA06164805/14/197410/31/1992
Labeler - Alcon Laboratories, Inc. (008018525)
Registrant - Alcon Laboratories, Inc. (008018525)
Establishment
NameAddressID/FEIBusiness Operations
Alcon Research Ltd007672236manufacture(0065-0641, 0065-0642)

Revised: 7/2006
 
Alcon Laboratories, Inc.